CAS 1648796-29-5

Gimsilumab

CAS: 1648796-29-5

Gimsilumab (MORAb-022) is an anti-c-Fms humanized monoclonal antibody for the study of inflammation and hypoxemia caused by COVID-19.

Reinheit: 99.49% (SEC-HPLC) - 99.49% (SEC-HPLC)

Farbe und Form: Transparent Liquid

Molekulargewicht: 145.8 kDa (Predicted)

Ref: TM-T77025

Gimsilumab

CAS: 1648796-29-5

Reinheit: 95%

Molekulargewicht: G/Mol

Ref: IN-DA02EOBS